Cipla falls 3%; CLSA downgrades to sell, target Rs 619

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Moneycontrol Bureau

Shares of Cipla fell 2.6 percent intraday Friday. Brokerage CLSA downgraded the stock to a sell from underperform with target price of Rs 619 as it believes results of transformation could take longer than expected.

The new Cipla has completed its two years of investment phase and hence markets would expect execution soon, said the brokerage in its note.

According to the report, capacity constraints, ramp up in R&D spend and adjusting to a front end model could take longer than expected time to deliver.

While explaining about key triggers, CLSA said, "Inhalers, a key trigger, may offer only gradual upsides in the EU contrary to market expectations while the US opportunity is many years away. Launch of generic Nexium in the US by partner Teva is a key near term earnings driver."

Meanwhile, on Thursday, brokerage Bank of America Merrill Lynch (BoAML) also downgraded Cipla to neutral (from buy) despite being positive on its long-term prospects.

At 10:03 hours IST, the scrip of Cipla was quoting at Rs 711.05, down Rs 8.10, or 1.13 percent on the BSE.

Posted by Sunil Shankar Matkar